Savitri Chandrasekaran

Savitri Chandrasekaran

Auto-generated profile, based on publicly available information

Savitri Chandrasekaran

West Suffolk Hospital, Bury St Edmunds, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2025 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
SCSavitri Chandrasekaran
Savitri Chandrasekaran
MKMamta Kamboj
Mamta Kamboj
SBSnigdha Baddepudi
Snigdha Baddepudi
RRRishu Raj
Rishu Raj
CSChaitanya Suresh
Chaitanya Suresh
NWNishan Wijenaike
Nishan Wijenaike
Background: Coronavirus disease 2019 vaccines have been instrumental in combating the global pandemic, yet their potential side effects, including autoimmune conditions such as bullous pemphigoid, remain an area of concern. This case highlights the development of bullous pemphigoid following coronavirus disease 2019 vaccination and includes a comprehensive review of similar cases reported in the literature, emphasizing its novelty and clinical significance. Case presentation: An elderly British man in his 80s with type 2 diabetes mellitus developed blistering lesions 21 days after receiving his third dose of coronavirus disease 2019 vaccine (Moderna). Clinical examination revealed erythematous plaques and bullae on the trunk and limbs. Histopathological evaluation and immunofluorescence confirmed the diagnosis of bullous pemphigoid. Treatment included corticosteroids, doxycycline, and immunosuppressants. Despite initial improvement, a severe flare-up necessitated hospitalization and wound care management. A systematic review identified 50 reported cases of bullous pemphigoid linked to coronavirus disease 2019 vaccination, with the Pfizer-BioNTech vaccine implicated in most cases (64%), followed by Moderna (18%). Symptom onset typically occurred after the first dose in 52% of cases. Conclusion: This case underscores the need for vigilance regarding autoimmune phenomena such as bullous pemphigoid following coronavirus disease 2019 vaccination. Awareness of such potential adverse effects is crucial to ensure timely diagnosis and management, ultimately contributing to patient safety and guiding future vaccine development.